BIOCELTIX S.A. ZY -10 (XI3) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.062x

Based on the latest financial reports, BIOCELTIX S.A. ZY -10 (XI3) has a cash flow conversion efficiency ratio of -0.062x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.54 Million ≈ $-5.31 Million USD) by net assets (€73.28 Million ≈ $85.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BIOCELTIX S.A. ZY -10 market cap and net worth for the company's overall valuation and market capitalisation.

BIOCELTIX S.A. ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how BIOCELTIX S.A. ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BIOCELTIX S.A. ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BIOCELTIX S.A. ZY -10 ranked by their cash flow conversion efficiency. See XI3 operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Ritco Logistics Limited NSE:RITCO	0.019x
DIO Corporation KQ:039840	0.015x
Jasa Armada Indonesia Tbk PT JK:IPCM	0.109x
MHC Plantations Bhd KLSE:5026	0.202x
Kumho Electric KO:001210	-0.534x
Hyosung Itx KO:094280	0.371x
CURATIS N AG SW:CURN	-0.024x
Unique Engineering and Construction Public Company Limited BK:UNIQ	-0.190x

Annual Cash Flow Conversion Efficiency for BIOCELTIX S.A. ZY -10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of BIOCELTIX S.A. ZY -10 from 2021 to 2025. View XI3 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€73.28 Million ≈ $85.67 Million	€-11.95 Million ≈ $-13.97 Million	-0.163x	+64.34%
2024-12-31	€38.42 Million ≈ $44.91 Million	€-17.57 Million ≈ $-20.54 Million	-0.457x	+67.55%
2023-12-31	€10.47 Million ≈ $12.24 Million	€-14.75 Million ≈ $-17.24 Million	-1.409x	+7.84%
2022-12-31	€5.15 Million ≈ $6.02 Million	€-7.87 Million ≈ $-9.21 Million	-1.529x	-128.26%
2021-12-31	€6.00 Million ≈ $7.01 Million	€-4.02 Million ≈ $-4.70 Million	-0.670x	--

About BIOCELTIX S.A. ZY -10

F:XI3 Germany Biotechnology

Market Cap

$131.94 Million

€112.86 Million EUR

Market Cap Rank

#19685 Global

#1804 in Germany

Share Price

€20.40

Change (1 day)

+6.36%

52-Week Range

€14.08 - €24.35

All Time High

€28.60